Try our Advanced Search for more refined results

Bayer Should Stress Clot Risk On Yaz Label: FDA Panel

By Sindhu Sundar (December 8, 2011, 10:15 PM EST) -- A U.S. Food and Drug Administration panel reportedly recommended Thursday that Bayer AG revise the labels on its Yaz and Yasmin contraceptives to highlight increased blood clot risks associated with the drugs, but said the pills are a beneficial choice for contraception....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!